drugset / Trial / NCT00045747

UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer

NCT00045747

Open-labelTreatment

Summary

RATIONALE: UCN-01 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining UCN-01 with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining UCN-01 with fluorouracil in treating patients who have metastatic pancreatic cancer that has not responded to treatment with gemcitabine.

Timeline

Start
2002-07
Primary completion
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject UCN-01 Small molecule Intravenous
Subject fluorouracil Small molecule Intravenous